Researchers highlight ‘questionable’ data in Russian coronavirus vaccine trial results: A group of researchers have expressed concern about repetitive patterns of data in a paper describing early-phase clinical trials of Russia’s coronavirus vaccine — the first jab worldwide to be approved for widespread use.
In an open letter to the study authors, who published the trial results this month in The Lancet, the researchers highlight values that seem to be duplicated, and warn that the paper presents its results only as box plots without providing a detailed breakdown of the data on which they are based.
